Matrix metalloproteinase inhibitors reduce collagen gel contraction and -smooth muscle actin expression by periodontal ligament cells

Journal of Periodontal Research

Volumn 44, Issue 2, 2009, Pages 266-274

  Bildt, M M ^a   Bloemen, M ^a   Kuijpers Jagtman, A M ^a   Von Den Hoff, J W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Matrix metalloproteinase; Matrix metalloproteinase inhibitors; Periodontal ligament; Zymography

Indexed keywords

ACTIN; BATIMASTAT; COLLAGEN; DOXYCYCLINE; DRUG DERIVATIVE; ILOMASTAT; INDOLE DERIVATIVE; MATRIX METALLOPROTEINASE; PHENYLALANINE; PROTEINASE INHIBITOR; TETRACYCLINE CMT 3; TETRACYCLINE CMT-3; TETRACYCLINE DERIVATIVE; THIOPHENE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; DENTAL CARE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR MATRIX; FIBROBLAST; GEL; HUMAN; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ACTINS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; COLLAGEN; DENTAL STRESS ANALYSIS; DOXYCYCLINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; FIBROBLASTS; GELS; HUMANS; INDOLES; MATRIX METALLOPROTEINASES; PERIODONTAL LIGAMENT; PHENYLALANINE; PROTEASE INHIBITORS; TETRACYCLINES; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASES; TOOTH MOVEMENT;

EID: 60849101384     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01127.x     Document Type: Article

References (55)

1. Meikle MC. The tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after Carl Sandstedt. Eur J Orthod 2006 28 : 221 240.
2. McCulloch CAG, Lekic P, McKee MD. Role of physical forces in regulating the form and function of the periodontal ligament. Periodontol 2000 2000 24 : 56 72.
3. Berkovitz BKB, Moxham BJ, Newman HN. The Periodontal Ligament in Health and Disease, 2nd edition. St Louis, USA : Mosby-Year Book, 1995.
4. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004 10 : 311 318.
5. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006 69 : 562 573.
6. Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 2006 85 : 1074 1084.
7. Peterson JT. The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitors. Cardiovasc Res 2006 69 : 677 687.
8. Dezube BJ, Krown SE, Lee LY, Bauer KS, Aboulafia DM. Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. J Clinical Oncol 2006 24 : 1389 1394.
9. Holliday LS, Vakani A, Archer L, Dolce C. Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement. J Dent Res 2003 82 : 687 691.
10. Bildt MM, Henneman S, Maltha JC, Kuijpers-Jagtman AM, Von den Hoff JW. CMT-3 inhibits orthodontic tooth movement in the rat. Arch Oral Biol 2007 52 : 571 578.
11. Moalli PA, Klingensmith WL, Meyn LA. Increased expression of matrix metalloproteinases in the uterine cervix of postmenopausal women. J Low Genit Tract Dis 2003 7 : 36 43.
12. Lobmann R, Pap T, Ambrosch A, Waldmann K, König W, Lehnert H. Differential effects of PDGF-BB on matrix metalloproteases and cytokine release in fibroblasts of Type 2 diabetic patients and normal controls in vitro. J Diabetes Complications 2006 20 : 105 112.
13. Asano K, Sakai M, Matsuda T, Tanaka H, Fujii K, Hisamitsu T. Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro. J Pharm Pharmacol 2006 58 : 359 366.
14. Nahm DS, Kim HJ, Mah J, Baek SH. In vitro expression of matrix metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and transforming growth factor beta1 in human periodontal ligament fibroblasts. Eur J Orthod 2004 26 : 129 135.
15. Tiranathanagul S, Pattamapun K, Yongchaitrakul T, Pavasant P. MMP-2 activation by Actinobacillus actinomycetemcomitans supernatant in human PDL cells was corresponded with reduction of TIMP-2. Oral Dis 2004 10 : 383 388.
16. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS. Regulation of matrix metalloproteinase production by cytokines, pharmacological agents and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodontal Res 2002 37 : 196 203.
17. Uitto VJ, Firth JD, Nip L, Golub LM. Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann N Y Acad Sci 1994 732 : 140 151.
18. Bildt MM, Snoek-Van Beurden AM, DeGroot J, Van El B, Kuijpers-Jagtman AM, Von den Hoff JW. Chemically modified tetracyclines stimulate matrix metalloproteinase-2 production by periodontal ligament cells. J Periodontal Res 2006 41 : 463 470.
19. Mäkelä M, Sorsa T, Uitto VJ, Salo T, Teronen O, Larjava H. The effects of chemically modified tetracyclines (CMTs) on human keratinocytes proliferation and migration. Adv Dent Res 1998 12 : 131 135.
20. Huang GF, Sonoyama W, Chen J, Park SH. In vitro characterization of human dental pulp cells: various isolation methods and culturing environments. Cell Tissue Res 2006 324 : 225 236.
21. Schindler M, Nur E, Kamal A et al. Living in three dimensions: 3D nanostructured environments for cell culture en regenerative medicine. Cell Biochem Biophys 2006 45 : 215 227.
22. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 2003 13 : 264 269.
23. Doljanski F. The sculpturing role of fibroblast-like cells in morphogenesis. Perspect Biol Med 2004 47 : 339 356.
24. Johnston DE, Bougher DR, Cimini M, Rogers KA. Radial artery as an autologous cell source for valvular tissue engineering efforts. J Biomed Mater Res A 2006 78 : 383 393.
25. Wong WR, Kossodo S, Kochevar IE. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels. J Formos Med Assoc 2001 100 : 377 382.
26. Von den Hoff JW. Effects of mechanical tension on matrix degradation by human periodontal ligament cells cultured in collagen gels. J Periodontal Res 2003 38 : 449 457.
27. Tsuji K, Uno K, Zhang GX, Tamura M. Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloproteinase-1 and -2. J Bone Miner Metab 2004 22 : 94 103.
28. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994 124 : 401 404.
29. Sukotjo C, Lin A, Song K, Ogawa T, Wu B, Nishimura I. Oral fibroblast expression of wound-inducible transcript 3.0 (wit3.0) accelerates the collagen gel contraction in vitro. J Biol Chem 2003 278 : 51527 51534.
30. Daniels JT, Cambrey AD, Occleston NL et al. Matrix metalloproteinases inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 2003 44 : 1104 1110.
31. Fredriksson K, Liu XD, Lundahl J, Klominek J, Rennard SI, Skold CM. Red blood cells increase secretion of matrix metalloproteinases from human lung fibroblasts in vitro. Am J Physiol Lung Cell Mol Physiol 2006 290 : 326 333.
32. Pins GD, Collins-Pavao ME, Van de Water L, Yarmush ML, Morgan JR. Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. J Invest Dermatol 2000 114 : 647 653.
33. Waas ET, Lomme RM, DeGroot J, Wobbes T, Hendriks T. Tissue levels of matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 2002 86 : 1876 1883.
34. Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem 1995 270 : 6351 6356.
35. Myers SA, Wolowacz RG. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro. Adv Dent Res 1998 12 : 86 93.
36. Beekman B, Drijfhout JW, Bloemhoff W, Ronday HK, Tak PP, te Koppele JM. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media. FEBS Lett 1996 390 : 221 225.
37. Langholz O, Röckel D, Mauch C et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995 131 : 1903 1915.
38. Phillips JA, Bonassar LJ. Matrix metalloproteinase activity synergizes with 21 integrins to enhance collagen remodeling. Exp Cell Res 2005 310 : 79 87.
39. McKeown STW, Barnes JJ, Hyland PL, Lundy FT, Fray MJ, Irwin CR. Matrix metalloproteinase-3 differences in oral and skin fibroblasts. J Dent Res 2007 86 : 457 462.
40. Toriseva MJ, Ala-aho R, Karvinen J et al. Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes surviavl of skin fibroblasts. J Invest Dermatol 2007 127 : 49 59.
41. Van beurden HE, Von den Hoff JW, Torensma R, Maltha JC, Kuijpers-Jagtman AM. Myofibroblasts in palatal wound healing: prospects for the reduction of wound contraction after cleft palate repair. J Dent Res 2005 10 : 871 880.
42. Meshel AS, Wei Q, Adelstein RS, Sheetz MP. Basic mechanism of three-dimensional collagen fibre transport by fibroblasts. Nat Cell Biol 2005 7 : 157 164.
43. Prajapati RT, Eastwood M, Brown RA. Duration and orientation of mechanical loads determine fibroblast cyto-mechanical activation: monitored by protease release. Wound Repair Regen 2000 8 : 238 246.
44. Prajapati RT, Chavally-Mis B, Herbage D, Eastwood M, Brown RA. Mechanical loading regulates protease production by fibroblasts in three-dimensional collagen substrates. Wound Repair Regen 2000 8 : 226 237.
45. Maeda S, Dean DD, Gomez R, Schwartz Z, Boyan BD. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int 2002 70 : 54 65.
46. Morishima Y, Nomura A, Uchida Y et al. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol 2001 24 : 1 11.
47. Knäuper V, Wilhelm SM, Seperack PK et al. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 1993 295 : 581 586.
48. Dreier R, Grässel S, Fuchs S, Schaumburger J, Bruckner P. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell Res 2004 297 : 303 312.
49. Kerkvliet EH, Jansen ID, Schoenmaker TA, Docherty AJ, Beertsen W, Everts V. Low molecular weight inhibitors of matrix metalloproteinases can enhance the expression of matrix metalloproteinase-2 (gelatinase A) without inhibiting its activation. Cancer 2003 15 : 1582 1588.
50. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J 1992 285 : 603 611.
51. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-. J Immunol 1999 162 : 5528 5535.
52. Takahra T, Smart DE, Oakley F, Mann DA. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-B, AP-1 and Sp1. Int J Biochem Cell Biol 2004 36 : 353 363.
53. LaMarca HL, Ott CM, Höner zu Bentrup K et al. Three-dimensional growth of extravillous cytotrophoblasts promotes differentiation and invasion. Placenta 2005 26 : 709 720.
54. Imai K, Sato T, Senoo H. Adhesion between cells and extracellular matrix with special reference to hepatic stellate cell adhesion to three-dimensional collagen fibers. Cell Struct Funct 2000 25 : 329 336.
55. Abécassis I, Olofsson B, Schmid M, Zalcman G, Karniguian A. RhoA induces MMP-9 expression at CD44 lamellipodial focal complexes and promotes HMEC-1 cell invasion. Exp Cell Res 2003 291 : 363 373.